A new editorial was published in Volume 12 of Oncoscience on May 2, 2025, titled "Immune checkpoint inhibitors and myocarditis: Lessons from a nationwide cohort study." In this editorial, Bishal ...

Efficacy and safety of nivolumab plus chemotherapy versus chemotherapy alone for the treatment of advance non-small cell lung cancer: A systematic review and meta-analysis of randomized controlled ...

The impacts on prognosis of the relationship between decline in renal function associated with pemetrexed and the ratio of pemetrexed administration. This is an ASCO Meeting Abstract from the 2025 ...

Whether survival with immune checkpoint inhibitors for cancer is enhanced or diminished for patients with pre-existing rheumatoid arthritis is uncertain. This study used Medicare claims data for ...

Zoldonrasib ideal for further evaluation in KRAS G12D-mutant disease, expert says ...

A meta-analysis of 29 studies found that earlier administration of immune checkpoint inhibitors was associated with longer overall and progression-free survival in advanced solid tumors. Benefits were ...

ANKTIVA, in combination with an immune checkpoint inhibitor, has received accelerated approval from the Saudi Food and Drug Authority for the treatment of metastatic non-small cell lung cancer, ...

Please provide your email address to receive an email when new articles are posted on . Patients with rheumatoid arthritis who receive immune checkpoint inhibition for metastatic lung cancer have ...